.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Prospective observational data have suggested that the trajectory of venous congestion may carry more information than a single VExUS measurement. In a general ICU cohort, investigators measured VExUS on admission and again during the first three days, then examined the relationship between change in score and major adverse kidney events. The study found that the early change in VExUS score was associated with MAKE-30, whereas an isolated score on day 1 or day 3 was not. This supports the idea that congestion is dynamic and that the direction of change may be clinically meaningful. For HCPs, this has a practical implication: bedside ultrasound can be most useful when incorporated into serial assessment rather than used as a one-time label. A patient's venous congestion can rise or fall as fluids, vasopressors, ventilation and renal function change. This fits the conference's emphasis on dynamic haemodynamic monitoring, personalised resuscitation and ultrasound-guided volume strategy. The evidence remains observational, so VExUS should not yet be treated as a validated trigger for a specific therapy. However, serial imaging may help clinicians recognise when the haemodynamic phase of care has shifted—from resuscitation toward de-resuscitation or organ-protection.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Prospective observational data have suggested that the trajectory of venous congestion may carry more information than a single VExUS measurement. In a general ICU cohort, investigators measured VExUS on admission and again during the first three days, then examined the relationship between change in score and major adverse kidney events. The study found that the early change in VExUS score was associated with MAKE-30, whereas an isolated score on day 1 or day 3 was not. This supports the idea that congestion is dynamic and that the direction of change may be clinically meaningful. For HCPs, this has a practical implication: bedside ultrasound can be most useful when incorporated into serial assessment rather than used as a one-time label. A patient's venous congestion can rise or fall as fluids, vasopressors, ventilation and renal function change. This fits the conference's emphasis on dynamic haemodynamic monitoring, personalised resuscitation and ultrasound-guided volume strategy. The evidence remains observational, so VExUS should not yet be treated as a validated trigger for a specific therapy. However, serial imaging may help clinicians recognise when the haemodynamic phase of care has shifted—from resuscitation toward de-resuscitation or organ-protection.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
